Profile | GDS5420 / 221513_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 945.65 | 78 |
GSM1296119 | B_lesional_pre-dose | 490.17 | 67 |
GSM1296076 | C_lesional_pre-dose | 535.75 | 70 |
GSM1296092 | D_lesional_pre-dose | 529.12 | 69 |
GSM1296103 | E_lesional_pre-dose | 1042.21 | 80 |
GSM1296078 | F_lesional_pre-dose | 383.51 | 65 |
GSM1296107 | G_lesional_pre-dose | 598.44 | 71 |
GSM1296109 | H_lesional_pre-dose | 991.72 | 79 |
GSM1296080 | I_lesional_pre-dose | 740.4 | 74 |
GSM1296090 | J_lesional_pre-dose | 545.69 | 70 |
GSM1296074 | K_lesional_pre-dose | 485.06 | 68 |
GSM1296111 | L_lesional_pre-dose | 423.99 | 65 |
GSM1296099 | M_lesional_pre-dose | 771.59 | 75 |
GSM1296086 | O_lesional_pre-dose | 688.41 | 73 |
GSM1296117 | P_lesional_pre-dose | 543.16 | 69 |
GSM1296113 | Q_lesional_pre-dose | 461.79 | 66 |
GSM1296096 | R_lesional_pre-dose | 833.15 | 76 |
GSM1296105 | S_lesional_pre-dose | 679.04 | 72 |
GSM1296098 | T_lesional_pre-dose | 803.59 | 76 |
GSM1296101 | U_lesional_pre-dose | 893.51 | 77 |
GSM1296121 | V_lesional_pre-dose | 618.47 | 71 |
GSM1296088 | W_lesional_pre-dose | 660.65 | 72 |
GSM1296082 | X_lesional_pre-dose | 554.3 | 70 |
GSM1296115 | Y_lesional_pre-dose | 596.18 | 71 |
GSM1296084 | Z_lesional_pre-dose | 560.44 | 70 |
GSM1296072 | B_lesional_day8 | 521.28 | 68 |
GSM1296069 | L_lesional_day8 | 443.17 | 65 |
GSM1296071 | P_lesional_day8 | 548.13 | 69 |
GSM1296070 | Y_lesional_day8 | 397.45 | 63 |
GSM1296073 | V_lesional_day8 | 581.55 | 71 |
GSM1296034 | A_lesional_day15 | 811.26 | 75 |
GSM1296041 | G_lesional_day15 | 439.27 | 66 |
GSM1296035 | R_lesional_day15 | 805.94 | 75 |
GSM1296038 | U_lesional_day15 | 514.57 | 68 |
GSM1296047 | B_lesional_day15 | 472.59 | 66 |
GSM1296039 | E_lesional_day15 | 554.62 | 70 |
GSM1296042 | H_lesional_day15 | 477.53 | 67 |
GSM1296043 | L_lesional_day15 | 435.5 | 65 |
GSM1296037 | M_lesional_day15 | 653.88 | 72 |
GSM1296046 | P_lesional_day15 | 326.26 | 59 |
GSM1296044 | Q_lesional_day15 | 488.98 | 67 |
GSM1296045 | Y_lesional_day15 | 363.37 | 61 |
GSM1296025 | C_lesional_day15 | 572.74 | 70 |
GSM1296033 | D_lesional_day15 | 364.65 | 62 |
GSM1296027 | I_lesional_day15 | 495.79 | 68 |
GSM1296032 | J_lesional_day15 | 371.41 | 62 |
GSM1296024 | K_lesional_day15 | 667.9 | 72 |
GSM1296031 | W_lesional_day15 | 659.11 | 72 |
GSM1296028 | X_lesional_day15 | 468.02 | 66 |
GSM1296029 | Z_lesional_day15 | 578.42 | 70 |
GSM1296026 | F_lesional_day15 | 496.05 | 68 |
GSM1296030 | O_lesional_day15 | 629.04 | 71 |
GSM1296040 | S_lesional_day15 | 851.37 | 76 |
GSM1296036 | T_lesional_day15 | 861.29 | 77 |
GSM1296048 | V_lesional_day15 | 567.89 | 70 |
GSM1296059 | A_lesional_day43 | 1041.83 | 80 |
GSM1296066 | G_lesional_day43 | 471.96 | 67 |
GSM1296060 | R_lesional_day43 | 804.41 | 75 |
GSM1296063 | U_lesional_day43 | 438.03 | 66 |
GSM1296064 | E_lesional_day43 | 589.55 | 71 |
GSM1296067 | H_lesional_day43 | 617.75 | 71 |
GSM1296062 | M_lesional_day43 | 1043.94 | 80 |
GSM1296068 | Q_lesional_day43 | 442.02 | 65 |
GSM1296050 | C_lesional_day43 | 336.84 | 61 |
GSM1296057 | D_lesional_day43 | 711.96 | 73 |
GSM1296052 | I_lesional_day43 | 417.16 | 65 |
GSM1296054 | J_lesional_day43 | 507.56 | 67 |
GSM1296049 | K_lesional_day43 | 568.27 | 70 |
GSM1296055 | W_lesional_day43 | 539.72 | 69 |
GSM1296053 | X_lesional_day43 | 427.43 | 65 |
GSM1296058 | Z_lesional_day43 | 756.59 | 74 |
GSM1296051 | F_lesional_day43 | 516.05 | 69 |
GSM1296056 | O_lesional_day43 | 611.34 | 71 |
GSM1296065 | S_lesional_day43 | 500.46 | 68 |
GSM1296061 | T_lesional_day43 | 939.35 | 78 |
GSM1296095 | A_non-lesional_pre-dose | 533.26 | 69 |
GSM1296120 | B_non-lesional_pre-dose | 494.91 | 67 |
GSM1296077 | C_non-lesional_pre-dose | 602.43 | 71 |
GSM1296093 | D_non-lesional_pre-dose | 580.95 | 70 |
GSM1296104 | E_non-lesional_pre-dose | 543.19 | 69 |
GSM1296079 | F_non-lesional_pre-dose | 564.5 | 70 |
GSM1296108 | G_non-lesional_pre-dose | 542.53 | 69 |
GSM1296110 | H_non-lesional_pre-dose | 632.23 | 71 |
GSM1296081 | I_non-lesional_pre-dose | 481.22 | 67 |
GSM1296091 | J_non-lesional_pre-dose | 391.88 | 64 |
GSM1296075 | K_non-lesional_pre-dose | 361.27 | 63 |
GSM1296112 | L_non-lesional_pre-dose | 369.35 | 61 |
GSM1296100 | M_non-lesional_pre-dose | 706.18 | 73 |
GSM1296087 | O_non-lesional_pre-dose | 285.63 | 59 |
GSM1296118 | P_non-lesional_pre-dose | 529.71 | 68 |
GSM1296114 | Q_non-lesional_pre-dose | 527.92 | 68 |
GSM1296097 | R_non-lesional_pre-dose | 541.53 | 69 |
GSM1296106 | S_non-lesional_pre-dose | 596.67 | 70 |
GSM1296102 | U_non-lesional_pre-dose | 472.87 | 66 |
GSM1296122 | V_non-lesional_pre-dose | 389.19 | 63 |
GSM1296089 | W_non-lesional_pre-dose | 458.2 | 66 |
GSM1296083 | X_non-lesional_pre-dose | 557.07 | 69 |
GSM1296116 | Y_non-lesional_pre-dose | 498.04 | 67 |
GSM1296085 | Z_non-lesional_pre-dose | 379.75 | 63 |